Comparing the number of EFNS, AAN, and study criteria met between treatment responders and non-responders.

Mean and standard deviation are indicated.CIDP: Chronic inflammatory demyelinating polyradiculoneuropathy; DM: Diabetes mellitusEFNS criteria include one of four demyelinating features: reduction in conduction velocity, distal latency or F wave prolongation, or conduction blocks in 2 nerves. AAN criteria include three of four demyelinating features: reduction in conduction velocity, distal latency or F wave prolongation, or conduction blocks in 2 nerves.* Study parameters, including 10% reduction in conduction velocity, distal latency or F wave prolongation, and conduction blocks, from any of the nerves tested.** Study parameters, including 30% reduction in conduction velocity, distal latency or F wave prolongation, and conduction blocks, from any of the nerves tested.Comparing the number of EFNS, AAN, and study criteria met between treatment responders and non-responders.